{"id":"W2989418474","doi":"10.1182/blood-2019-123961","title":"Exposure-Response Analyses Indicate a Promising Benefit/Risk Profile of Mosunetuzumab in Relapsed and Refractory Non-Hodgkin Lymphoma","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Cmax; Medicine; Dosing; Rituximab; Internal medicine; Refractory (planetary science); Population; Regimen; Pharmacodynamics; Pharmacokinetics; Oncology; Pharmacology; Lymphoma; Gastroenterology; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002607956,0.0002811363,0.0005776539,0.000306827,0.0001110871,0.0004371306,0.0001911213,0.0002993317,0.001845038],"category_scores_gemma":[0.002242416,0.0001279512,0.0005944674,0.000246389,0.0001905828,0.0003981664,0.0002049698,0.0007820957,0.0002910033],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004074688,"about_ca_system_score_gemma":0.0001991172,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002895888,"about_ca_topic_score_gemma":0.0005163188,"domain_scores_codex":[0.9992425,0.0003220138,0.00007004034,0.0001222885,0.000178491,0.00006464354],"domain_scores_gemma":[0.998776,0.0005110638,0.0003852697,0.0001646954,0.00006254138,0.000100404],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.1489417,0.004443347,0.2516578,0.0005720263,0.003089338,0.0004334458,0.0004133225,0.01039627,0.1267718,0.0003856544,0.00186718,0.4510283],"study_design_scores_gemma":[0.007045591,0.09930965,0.8416983,0.00005577224,0.001847267,0.001566978,0.0001073774,0.009865203,0.03109277,0.0009267819,0.006442975,0.0000413172],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.996705,0.000902336,0.0007985662,0.00006148766,0.000003720223,0.0001060713,0.0003503758,0.00003998446,0.001032506],"genre_scores_gemma":[0.9990068,0.0001252032,0.0002284386,0.00005119593,0.000008377984,0.00002309865,0.0002595675,0.000005512334,0.0002919443],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002607956,"threshold_uncertainty_score":0.01379234,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0209038941956767,"score_gpt":0.3141236991618455,"score_spread":0.2932198049661688,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}